Latest COVID-19 Update and Vaccination Guidelines by Dr. Thomas Dobbs

Slide Note
Embed
Share

In the latest update, Dr. Thomas Dobbs emphasizes the importance of COVID-19 vaccination for individuals above 4 years old, with special attention to those above 11 years old. Updated vaccines like Pfizer, Moderna, and Novavax are recommended, with a reminder for those due for vaccination since September 12, 2023. High-risk individuals, especially those over 50, unvaccinated, or with chronic conditions, are advised to seek early treatment with antiviral medications like Paxlovid, Remdesivir, and Molnupiravir. Immediate intervention within 5 days of symptoms onset is crucial for effective treatment.


Uploaded on Nov 15, 2024 | 0 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

E N D

Presentation Transcript


  1. COVID-19 Update 2/15/2024 Thomas Dobbs, MD, MPH

  2. Key Messages COVID is still here Vaccination Everyone > 4 years of age recommended > 11 years old 1 updated vaccine (Pfizer, Moderna) 1 updated Novavax (2 if never vaccinated before) Updated vaccines available since Sept 12, 2023. So if you haven t gotten the vaccine since Sept you are due

  3. If you get COVID??? People > 50, unvaccinated, or with chronic medical conditions are at higher risk from COVID Physicians or providers can prescribe anti-COVID antiviral medications Paxlovid Remdesivir (infusion) Molnupiravir Must take early - < 5 days after symptoms and the sooner the better!

Related


More Related Content